Clinical trial
A Multi-centre, Prospective, Randomized Controlled Study to Compare Outcomes of Non-operative Management (NOM) With and Without Splenic Arterial Embolization (SAE) in Hemodynamically Stable OIS Grade 4 and 5 Splenic Injuries.
NCT03231202 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-centre, Prospective, Randomized Controlled Study to Compare Outcomes of Non-operative Management (NOM) With and Without Splenic Arterial Embolization (SAE) in Hemodynamically Stable OIS Grade 4 and 5 Splenic Injuries.
- Lead sponsor
- Oslo University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 1, 2017
- Completion date
- August 1, 2019
- Enrollment
- 224 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.